NIH #5P50CA101942-10
P3 - Acquired Resistance to VEGF Receptor Blockade: Underlying Mech & Therapeuti
- Amount
- $245K
- Period
- — → 2015-09-17
- PIs
- 1
- Est. capacity / PI
- ~4 students
Awarded at BETH ISRAEL DEACONESS MEDICAL CENTER
Christopher G. Wood
Full Professor(heuristic)
Renal cell carcinoma treatment · Pulmonary and Respiratory Medicine
h-index87
i10-index324
Publications787
Citations28,257
Grants
5 total · 0 active
NIH #5P50CA101942-07
P3 - Acquired Resistance to VEGF Receptor Blockade: Underlying Mech & Therapeuti
- Amount
- $262K
- Period
- 2010-06-01 → 2014-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BETH ISRAEL DEACONESS MEDICAL CENTER
NIH #2P50CA101942-06A1
Acquired Resistance to VEGF Receptor Blockade: Underlying Mechanisms & Therapeuti
- Amount
- $263K
- Period
- 2009-06-01 → 2014-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at BETH ISRAEL DEACONESS MEDICAL CENTER
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 3 of 3Hearing preservation and restoration surgery in NF2-related schwannomatosis
Familial Cancer · 2026-01-31
Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study
JAMA Network Open · 2025-11-05 · 4 citations
The Laryngoscope · 2025-06-13 · 3 citations